Trial intelligence / Profile preview

Endostar for Malignant Cavity Effusion

ChiCTR-IPR-17011666Phase 4Completed

Sponsor
Medical Department of Dalian University
Start
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of endostar in malignant pleural effusion (MPE) (3 arms), sponsored by Medical Department of Dalian University. Started May 2010; status: completed.

02

Drugs

endostar
03

Conditions

malignant pleural effusion (MPE)

Beyond the preview

Go deeper on ChiCTR-IPR-17011666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call